The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells
Abstract
Tumor cells fuel their metabolism with glucose and glutamine to meet the bioenergetic and biosynthetic demands of proliferation. Hypoxia and oncogenic mutations drive glycolysis, with the pyruvate to lactate conversion being promoted by increased expression of lactate dehydrogenase A and inactivation of pyruvate dehydrogenase. The NAD+ pool is consecutively regenerated and supports the high glycolytic flux required to produce anabolic intermediates. Glutaminolysis provides metabolic intermediates such as alpha-ketoglutarate to feed and thereby maintain the tricarboxylic acid cycle as a biosynthetic hub. Glycolysis and glutaminolysis share the capacity to generate NADPH, from the pentose phosphate pathway and through the malate conversion into pyruvate, respectively. Both pathways ultimately lead to the secretion of lactate. More than a waste product, lactate was recently identified as a major energy fuel in tumors. Lactate produced by hypoxic tumor cells may indeed diffuse and be taken up by oxygenated tumor cells. Preferential utilization of lactate for oxidative metabolism spares glucose which may in turn reach hypoxic tumor cells. Monocarboxylate transporter 1 regulates the entry of lactate into oxidative tumor cells. Its inhibition favors the switch from lactate-fuelled respiration to glycolysis and consecutively kills hypoxic tumor cells from glucose starvation. Combination with radiotherapy renders remaining cells more sensitive to irradiation, emphasizing how interference with tumor cell metabolism may complement current anticancer modalities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pyruvate is converted to acetyl-CoA through mitochondrial pyruvate dehydrogenase (PDH), whereas acetate is transported into cells and converted to acetyl-CoA through acetyl-CoA synthase (De Schrijver et al., 2003; Feron, 2009; Koukourakis et al., 2005; Pizer et al., 1996; Yoshimoto et al., 2001; Zaidi et al., 2012).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Feron, 2009
In the citing paper
“pyruvate or acetate can act as an alternative source to glucose and glutamine for lipid biosynthesis.”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Feron, 2009
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
On Respiratory Impairment in Cancer Cells
Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Shaw, R. J., & Cantley, L. C. (2006) · Nature · doi:10.1038/nature04869 · Cited by 2,019
Flagged first, then by citations
1 of the 38 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 561
Li, H., Zhang, X., Lin, X., Zhuang, S., Wu, Y., Liu, Z., Rong, J., & Zhao, J. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb02684c · Cited by 38
Radial spectroscopic MRI of hyperpolarized [1-13C] pyruvate at 7 tesla
Ramirez, M. S., Lee, J.-H., Walker, C. M., Sandulache, V. C., Hennel, F., Lai, S. Y., & Bankson, J. A. (2013) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25004 · Cited by 38
Inhibition of tumor lactate oxidation: Consequences for the tumor microenvironment
Busk, M., Walenta, S., Mueller‐Klieser, W., Steiniche, T., Jakobsen, S., Horsman, M. R., & Overgaard, J. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.053 · Cited by 38
Huang, X., Liu, M., Sun, H., Wang, F., Xie, X., Chen, X. '., Su, J., He, Y., Dai, Y., Wu, H., et al. (2015) · Europe PMC (PubMed Central) · Cited by 38
Shi, H., Jiang, H., Wang, L., Cao, Y., Liu, P., Xu, X., Wang, Y., Sun, L., & Niu, H. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1053666 · Cited by 37
Recent Advances in the Biology, Therapy and Management of Melanoma
Davids, L. M. (2013) · InTech eBooks · doi:10.5772/46052 · Cited by 38
The Involvement of PPARs in the Peculiar Energetic Metabolism of Tumor Cells
Antonosante, A., d’Angelo, M., Castelli, V., Catanesi, M., Iannotta, D., Giordano, A., Ippoliti, R., Benedetti, E., & Cimini, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071907 · Cited by 37
Haghi‐Aminjan, H., Baeeri, M., Rahimifard, M., Alizadeh, A., Hodjat, M., Hassani, S., Asghari, M. H., Abdollahi, A., Didari, T., Hosseini, R., et al. (2018) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2018.09.008 · Cited by 37
Saka, W. A., Ayoade, T. E., Akhigbe, T. M., & Akhigbe, R. E. (2020) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2019-0313 · Cited by 37
Williams, M. D., Zhang, X., Belton, A., Xian, L., Huso, T. H., Park, J.-J., Siems, W. F., Gang, D. R., Resar, L. M. S., Reeves, R., et al. (2015) · Journal of Proteome Research · doi:10.1021/pr501084s · Cited by 36
Metabolic alterations in bladder cancer: applications for cancer imaging
Whyard, T. C., Waltzer, W. C., Waltzer, D., & Romanov, V. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.01.005 · Cited by 36
Valtorta, S., Salvatore, D., Rainone, P., Belloli, S., Bertoli, G. R., & Moresco, R. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165631 · Cited by 37
Kuchiiwa, T., Nio‐Kobayashi, J., Takahashi‐Iwanaga, H., Yajima, T., & Iwanaga, T. (2011) · Histochemistry and Cell Biology · doi:10.1007/s00418-011-0794-2 · Cited by 36
Zheng, W., Tayyari, F., Gowda, G. A. N., Raftery, D., McLamore, E. S., Shi, J. P., Porterfield, D. M., Donkin, S. S., Bequette, B. J., & Teegarden, D. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.03.012 · Cited by 36
Huang, M. H., Yang, X., Zhou, Y., Ge, J., Davis, D. A., Dong, Y., Gao, Q., & Dong, S. (2021) · Marine Life Science & Technology · doi:10.1007/s42995-020-00088-2 · Cited by 35
Metabolic response to radiation therapy in cancer
Read, G. H., Bailleul, J., Vlashi, E., & Kesarwala, A. H. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23379 · Cited by 41
Hamabe, A., Yamamoto, H., Konno, M., Uemura, M., Nishimura, J., Hata, T., Takemasa, I., Mizushima, T., Nishida, N., Kawamoto, K., et al. (2014) · Cancer Science · doi:10.1111/cas.12487 · Cited by 35
Zhang, G., Ahola, S., Lerche, M. H., Telkki, V., & Hilty, C. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b03096 · Cited by 35
Understanding and Targeting Apoptotic Pathways in Ovarian Cancer
Al-Alem, L., Baker, A. T., Pandya, U. M., Eisenhauer, E. L., & Rueda, B. R. (2019) · Cancers · doi:10.3390/cancers11111631 · Cited by 36
Jin, L., Kim, E.-Y., Chung, T., Han, C. W., Park, M.-J., Han, J. H., Bae, S., Lee, J. R., Kim, Y. W., Jang, S. B., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-79019-1 · Cited by 35
Lactate at the crossroads of tumor metabolism and immune escape: a new frontier in cancer therapy
Dong, Z., Yuan, Z., Jin, T., Gao, C., Wang, X., & Xu, F. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07272-x · Cited by 34
Linden, C. V., & Corbet, C. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.016 · Cited by 34
Menzel, M. I., Farrell, E. V., Janich, M., Khegai, O., Wiesinger, F., Nekolla, S. G., Otto, A. M., Haase, A., Schulte, R. F., & Schwaiger, M. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.110825 · Cited by 34
Yu, W. S., Jeong, S., Kim, J., Lee, H., Song, H. S., Kim, M., Ko, E., Lee, H., Khil, J., Jang, H.-J., et al. (2011) · Molecules and Cells · doi:10.1007/s10059-011-2254-1 · Cited by 34
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Lv, K., & He, T. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00233-8 · Cited by 36
Li, Y., Zhu, X., Liang, H., Orvig, C., & Chen, Z. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200505085756 · Cited by 34
Li, L., Feng, C., Qin, J., Li, D., Liu, M., Han, S., & Zheng, B. Q. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104409 · Cited by 37
Silver, A., Feier, D., Ghosh, T., Rahman, M., Huang, J., Sarkisian, M. R., & Deleyrolle, L. P. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1022716 · Cited by 36
Hutschenreuther, A., Birkenmeier, G., Bigl, M., Krohn, K., & Birkemeyer, C. (2013) · Metabolites · doi:10.3390/metabo3041084 · Cited by 33
Benedetti, E., d’Angelo, M., Ammazzalorso, A., Gravina, G. L., Laezza, C., Antonosante, A., Panella, G., Cinque, B., Cristiano, L., Dhez, A. C., et al. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25648 · Cited by 33
Zhou, Q., Xu, J., Liu, M., He, L., Zhang, K., Yang, Y., Yang, X., Zhou, H., Tang, M., Lu, L., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28218 · Cited by 32
Wang, D., Hartman, R. A., Han, C., Zhou, C., Couch, B. K., Malkamaki, M., Roginskaya, V. Y., Houten, B. V., Mullett, S. J., Wendell, S. G., et al. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02501-2 · Cited by 33
MicroRNAs as Regulators of Cancer Cell Energy Metabolism
Natarajaseenivasan, S. M., Velusamy, P., Mercy, C. S. A., Langford, D., Natarajaseenivasan, K., & Shanmughapriya, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12081329 · Cited by 35
An integrative theory for cancer (Review)
Luo, G., & Liu, N. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.4004 · Cited by 33
Abolhassani, M., Guais, A., Sanders, E. B., Campion, F., Fichtner, I., Bonte, J. T., Baronzio, G., Fiorentini, G., Israël, M., & Schwartz, L. H. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9692-7 · Cited by 33
Abaffy, T., Moller, M. G., Riemer, D. D., & Milikowski, C. (2011) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000076 · Cited by 32
Urata, K., Kajihara, I., Miyauchi, H., Myangat, T. M., Otsuka‐Maeda, S., Sakamoto, R., Sawamura, S., Kanemaru, H., Kanazawa‐Yamada, S., Makino, K., et al. (2019) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16145 · Cited by 31
Altered glucose metabolism in Harvey-rastransformed MCF10A cells
Zheng, W., Tayyari, F., Gowda, G. A. N., Raftery, D., McLamore, E. S., Porterfield, D. M., Donkin, S. S., Bequette, B. J., & Teegarden, D. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22079 · Cited by 34
Hée, V. F. V., Labar, D., Dehon, G., Grasso, D., Grégoire, V., Muccioli, G. G., Frédérick, R., & Sonveaux, P. (2017) · Oncotarget · doi:10.18632/oncotarget.14705 · Cited by 34
Aberrant mitochondrial function in ageing and cancer
Whitehall, J. C., & Greaves, L. C. (2019) · Biogerontology · doi:10.1007/s10522-019-09853-y · Cited by 34
Caveolin‐1 in oncogenic metabolic symbiosis
Raudenská, M., Gumulec, J., Balvan, J., & Masařík, M. (2020) · International Journal of Cancer · doi:10.1002/ijc.32987 · Cited by 32
From gametogenesis and stem cells to cancer: common metabolic themes
Pereira, S. L., Rodrigues, A. S., Sousa, M. I., Correia, M., Perestrelo, T., & Ramalho‐Santos, J. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu034 · Cited by 33
Euceda, L. R., Haukaas, T. H., Giskeødegård, G. F., Vettukattil, R., Engel, J., Silwal‐Pandit, L., Lundgren, S., Borgen, E., Garred, Ø., Postma, G., et al. (2017) · Metabolomics · doi:10.1007/s11306-017-1168-0 · Cited by 29
Li, F., Zhan, L., Dong, Q., Wang, Q., Wang, Y., Li, X., Zhang, Y., & Zhang, J. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s253485 · Cited by 29
Mitoribosomal small subunit maturation involves formation of initiation-like complexes
Lenarčič, T., Niemann, M., Ramrath, D. J. F., Calderaro, S., Flügel, T., Saurer, M., Leibundgut, M., Boehringer, D., Prange, C. J., Horn, E. K., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2114710118 · Cited by 29
Targeting anticancer immunity in oral cancer: Drugs, products, and nanoparticles
Qin, L., & Wu, J. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116751 · Cited by 29
Lin, G., & Chung, Y. (2014) · BioMed Research International · doi:10.1155/2014/625095 · Cited by 31
Alkhathami, A. G., Sahib, A. S., Fayi, M. S. A., Fadhil, A. A., Jawad, M. A., Shafik, S. A., Sultan, S. J., Almulla, A. F., & Shen, M. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116007 · Cited by 28
Mitochondrial lactate metabolism is involved in antioxidative defense in human astrocytoma cells
Lemire, J. A., Auger, C., Mailloux, R. J., & Appanna, V. D. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23338 · Cited by 28
1H NMR and hyperpolarized 13C NMR assays of pyruvate–lactate: a comparative study
Hill, D. K., Jamin, Y., Orton, M. R., Tardif, N., Parkes, H. G., Robinson, S. P., Leach, M. O., Chung, Y., & Eykyn, T. R. (2013) · NMR in Biomedicine · doi:10.1002/nbm.2957 · Cited by 28
Archetti, M. (2015) · Cell Proliferation · doi:10.1111/cpr.12169 · Cited by 28
Elucidation of How Cancer Cells Avoid Acidosis through Comparative Transcriptomic Data Analysis
Xu, K., Mao, X., Mehta, M., Cui, J., Zhang, C., Mao, F., & Xu, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071177 · Cited by 28
High-glycolytic cancers and their interplay with the body’s glucose demand and supply cycle
Mathews, E. H., Liebenberg, L., & Pelzer, R. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.09.006 · Cited by 28
Causes and Consequences of A Glutamine Induced Normoxic HIF1 Activity for the Tumor Metabolism
Kappler, M., Pabst, U., Weinholdt, C., Taubert, H. W., Rot, S., Kaune, T., Kotrba, J., Porsch, M., Güttler, A., Bache, M., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194742 · Cited by 29
Ghosh, A., Ghosh, A. K., Chowdhury, M., & Das, P. K. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00235 · Cited by 28
Regulation of glycolysis in head and neck squamous cell carcinoma
Kumar, D. (2017) · Postdoc Journal · doi:10.14304/surya.jpr.v5n1.4 · Cited by 29
Novel insight into the Warburg effect: Sweet temptation
Zhang, H., Liu, S., Fu, S., Zhao, Q., Wang, Y., Yuan, Y., & Zhang, C. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104844 · Cited by 33
Polymeric Nanocarriers for Drug Delivery in Osteosarcoma Treatment
Gu, X., Ding, J., Zhang, Z., Li, Q., Zhuang, X., & Chen, X. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150923095618 · Cited by 27
Lameirinhas, A., Miranda‐Gonçalves, V., Henrique, R., & Jerónimo, C. (2019) · Genes · doi:10.3390/genes10040264 · Cited by 28
He, M., Chi, X., Shi, X., Sun, Y., Yang, X. C., Wang, L., Wang, B., & Li, H. (2021) · Thoracic Cancer · doi:10.1111/1759-7714.13581 · Cited by 27
Yin, C., Jiang, C., Liao, F., Rong, Y., Cai, X., Guo, G., Qiu, H., Chen, X., Zhang, B., He, W., et al. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s64559 · Cited by 26
STAT3:FOXM1 and MCT1 drive uterine cervix carcinoma fitness to a lactate-rich microenvironment
Silva, L. S., Gonçalves, L. G., SILVA, F. A. B. N. D., Domingues, G., Máximo, V., Ferreira, J. C. M., Lam, E. W. ‐., Dias, S., Félix, A., & Serpa, J. (2015) · Tumor Biology · doi:10.1007/s13277-015-4385-z · Cited by 26
Photochemical Targeting of Mitochondria to Overcome Chemoresistance in Ovarian Cancer †
Rickard, B. P., Overchuk, M., Obaid, G., Ruhi, M. K., Demirci, U., Fenton, S. E., Santos, J. H., Kessel, D. H., & Rizvi, I. (2022) · Photochemistry and Photobiology · doi:10.1111/php.13723 · Cited by 26
The crosstalking of lactate‐Histone lactylation and tumor
Rong, Y., Dong, F., Zhang, G., Tang, M., Zhao, X., Zhang, Y., Tao, P., & Cai, H. (2023) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.202200102 · Cited by 26
Huang, R., Gao, H., Zhang, L., Jia, J., Liu, X., Zheng, P., Ma, L., Li, W., Deng, J., Wang, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044665 · Cited by 26
Al-Jarrah, M. D. (2010) · Journal of Clinical Medicine Research · doi:10.4021/jocmr444e · Cited by 25
A laktátdehidrogenáz (LDH) prognosztikai jelentősége az onkológiában
Deme, D., & Telekes, A. (2017) · Orvosi Hetilap · doi:10.1556/650.2017.30890 · Cited by 26
The conditional role of inflammation in pregnancy and cancer
Soeters, P. B., & Grimble, R. F. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2012.07.010 · Cited by 24
Sarkar, A., Pawar, S. V., Chopra, K., & Jain, M. K. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167021 · Cited by 24
Characterization of the role of TMEM45A in cancer cell sensitivity to cisplatin
Schmit, K., Chen, J., Ayama-Canden, S., Fransolet, M., Finet, L., Demazy, C., D'Hondt, L. A., Graux, C., & Michiels, C. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2088-x · Cited by 23
Metabolic Pathways Regulating Colorectal Cancer: A Potential Therapeutic Approach
Zafari, N., Velayati, M., Damavandi, S., Pourali, G., Ghayour‐Mobarhan, M., Nassiri, M., Hassanian, S. M., Khazaei, M., Ferns, G. A., & Avan, A. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220922111342 · Cited by 23
Lactate dehydrogenase is associated with flow-mediated dilation in hypertensive patients
Cai, X., Wang, T., & Xie, L. (2023) · Scientific Reports · doi:10.1038/s41598-023-27614-3 · Cited by 24
Molecular MRI-Based Monitoring of Cancer Immunotherapy Treatment Response
Vladimirov, N., & Perlman, O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043151 · Cited by 25
Bioactive food components, cancer cell growth limitation and reversal of glycolytic metabolism
Keijer, J., Bekkenkamp‐Grovenstein, M., Venema, D. P., & Dommels, Y. E. M. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.08.007 · Cited by 25
Multicompartment metabolism in papillary thyroid cancer
Curry, J., Tassone, P. T., Cotzia, P., Sprandio, J. D., Luginbuhl, A., Cognetti, D. M., Mollaee, M., Domingo‐Vidal, M., Pribitkin, E. A., Keane, W. M., et al. (2015) · The Laryngoscope · doi:10.1002/lary.25799 · Cited by 24
Hu, N., Li, H., Tao, C., Xiao, T., & Rong, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115584 · Cited by 28
Targeting energy metabolism of cancer cells: Combined administration of NCL-240 and 2-DG
Pattni, B. S., Jhaveri, A. M., Dutta, I., Baleja, J., Degterev, A., & Torchilin, V. P. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.08.095 · Cited by 25
Xu, S., Zhou, Y., Geng, H., Song, D., Tang, J. P., Zhu, X., Yu, D., Hu, S., & Cui, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-16085-y · Cited by 23
Canonical and Non-Canonical Roles of PFKFB3 in Brain Tumors
Alvarez, R., Mandal, D., & Chittiboina, P. (2021) · Cells · doi:10.3390/cells10112913 · Cited by 23
A Systematic Role of Metabolomics, Metabolic Pathways, and Chemical Metabolism in Lung Cancer
Kannampuzha, S., Mukherjee, A. G., Wanjari, U. R., Gopalakrishnan, A. V., Murali, R., Namachivayam, A., Renu, K., Dey, A., Vellingiri, B., Madhyastha, H., et al. (2023) · Vaccines · doi:10.3390/vaccines11020381 · Cited by 24
McGillen, J. B., Kelly, M., Martínez‐González, A., Martin, N. K., Gaffney, E. A., Maini, P. K., & Pérez‐García, V. M. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.09.018 · Cited by 21
The role of lactate metabolism and lactylation in pulmonary arterial hypertension
Peng, T.-Y., Lu, J., Zheng, X.-L., Zeng, C. C., & He, Y. (2025) · Respiratory Research · doi:10.1186/s12931-025-03163-3 · Cited by 24
L-carnitine's role in KAATSU training- induced neuromuscular fatigue
Shen, L., Li, J., Chen, Y., Lu, Z., & Lyu, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109899 · Cited by 24
Alternative Energy: Breaking Down the Diverse Metabolic Features of Lung Cancers
Cargill, K. R., Hasken, W. L., Gay, C. M., & Byers, L. A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.757323 · Cited by 21
Mitochondrial ribosomal protein genes connected with Alzheimer’s and tellurite toxicity
Giudice, L. D., Alifano, P., Calcagnile, M., Schiavi, E. D., Bertapelle, C., Aletta, M., & Pontieri, P. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.02.006 · Cited by 21
Cunha, A., Rocha, A. C., Barbosa, F., Baião, A., Silva, P. M. A., Sarmento, B. F. C. C., & Queirós, O. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102021 · Cited by 21
Importance of lactate dehydrogenase (LDH) and monocarboxylate transporters (MCTs) in cancer cells
Hatami, H., Sajedi, A., Mir, S. M., & Memar, M. Y. (2022) · Health Science Reports · doi:10.1002/hsr2.996 · Cited by 21
ALDH1A1 promotes immune escape of tumor cells through ZBTB7B-glycolysis pathway
Wang, M., Wang, T., Wang, J., Yang, Y., Li, X., Chen, H., & Liao, J. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06943-9 · Cited by 21
Energy management – a critical role in cancer induction?
Garland, J. M. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.04.001 · Cited by 21
Differentiation of human neuroblastoma cells toward the osteogenic lineage by mTOR inhibitor
Carpentieri, A., Cozzoli, E., Scimeca, M., Bonanno, E., Sardanelli, A. M., & Gambacurta, A. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.244 · Cited by 22
Metabolic reprogramming and its clinical application in thyroid cancer (Review)
Wen, S., Zhang, T., Xue, D.-X., Wu, W.-L., Wang, Y., Wang, Y., Ji, Q., Zhu, Y., Qu, N., & Shi, R. (2019) · Oncology Letters · doi:10.3892/ol.2019.10485 · Cited by 21
Metabolic Alterations During the Growth of Tumour Spheroids
Bloch, K. M., Smith, H., Parsons, V. V. H., Gavaghan, D. J., Kelly, M., Fletcher, A. G., Maini, P. K., & Callaghan, R. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9757-7 · Cited by 22
Exploring the FMN binding site in the mitochondrial outer membrane protein mitoNEET
Tasnim, H., Landry, A. P., Fontenot, C. R., & Ding, H. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.05.004 · Cited by 20
Zeng, S., & Hu, X. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.05.097 · Cited by 20
Chung, I., Huang, W., Huang, Y.-T., Chen, M.-L., Tsai, A.-W., Wu, P.-Y., & Yuan, T.-T. T. (2023) · Oncology Reports · doi:10.3892/or.2023.8642 · Cited by 20
Marushima, H. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1142 · Cited by 22
LigGrep: a tool for filtering docked poses to improve virtual-screening hit rates
Ha, E. J., Lwin, C. T., & Durrant, J. D. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00471-2 · Cited by 20
Yang, D., Lü, H., Liu, Y., Mao, L., Hu, W., & Zhou, Z. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i15.1588 · Cited by 20
Masumoto, A., Kitai, T., Matsumoto, S., Kuroda, S., Kohsaka, S., Tachikawa, R., Seo, R., Doi, A., Tomii, K., Yonetsu, T., et al. (2021) · Journal of Cardiology · doi:10.1016/j.jjcc.2021.12.014 · Cited by 19
The hypoxic tissue microenvironment as a driver of mucosal inflammatory resolution
Cartwright, I. M., & Colgan, S. P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1124774 · Cited by 18
Metadata
- Authors
- Feron, O.
- Venue
- Radiotherapy and Oncology
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 92
- Issue
- 3
- Pages
- 329-333
- ISSN
- 0167-8140 (ISSN-L)
- OpenAlex
- W2002922559
- Cited by
- 559
- References
- 38
- Citations by year
- 2026: 13 · 2025: 37 · 2024: 25 · 2023: 28 · 2022: 40 · 2021: 50 · 2020: 44 · 2019: 37 · 2018: 32 · 2017: 30 · 2016: 38 · 2015: 32 · 2014: 35 · 2013: 42 · 2012: 17
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Radiotherapy and Oncology (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (submittedVersion)
- Funders
- Fonds De La Recherche Scientifique - FNRS
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- Warburg effect, cancer metabolism, lactate, pyruvate, glycolysis, glutaminolysis, NAD+ regeneration, NADPH, pentose phosphate pathway, MCT1, LDHA, pyruvate dehydrogenase, hypoxia, oxidative metabolism, TCA cycle, alpha-ketoglutarate, glucose deprivation, combined radiotherapy
- MeSH terms
- Cell Survival, Energy Metabolism, Glycolysis, Humans, NAD, NADP, Neoplasms, Oxidation-Reduction, Radiation Tolerance, Sensitivity and Specificity, Cell Hypoxia, Cell Death, Pyruvic Acid, Lactic Acid, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review